US equities |
MU $972.37 ▲+4.69% META $613.69 ▼-1.05% TSLA $401.10 ▼-1.56% SPCX $144.85 ▼-2.51% NVDA $217.21 ▼-0.33% SNDK $1,379.60 ▲+5.73% SKHY $163.96 ▲+12.79% STX $684.57 ▲+2.50%
FinancialContent

LB Pharmaceuticals Inc - Common Stock (NQ:LBRX)

40.02 +0.38 (+0.96%)
Delayed Quote Updated: 12:39 PM EDT, Oct 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about LB Pharmaceuticals Inc - Common Stock

News headline image
LB Pharmaceuticals Eyes 2027 Phase III Data for LB-102 in Schizophrenia ↗
LB Pharmaceuticals (NASDAQ:LBRX) outlined its clinical and commercial plans for LB-102, an investigational antipsychotic designed as a structural modification of amisulpride, during its first R&D Day... 
Via MarketBeat
News headline image
Nan Fung Group Sells $4.3 Million in Oculis Shares As Lead Drug Stumbles ↗
Oculis advances late-stage topical therapies for diabetic and neuro-ophthalmic eye diseases in the clinical-stage biotech sector. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Jazz Pharmaceuticals, Sigma Lithium, Zymeworks And Other Big Stocks Moving Higher On Monday ↗
 
Via Benzinga
News headline image
This Commerce Bancshares Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
 
Via Benzinga